National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sits in the top decile of US sponsors by registered trial count (#74 of 15,742 sponsors by registered trial count).
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): 490 sponsored US clinical trials, 50 recruiting.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsors 490 registered US clinical trials on ClinicalTrials.gov, 50 of them currently recruiting, and 398 completed. 69 of these trials are in Phase 3-4 (later-stage) and 178 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 25 trials.
Top-decile sponsor footprint
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ranks in the top decile of sponsors by registered trial count (#74 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
398 of 424 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
490 total, page 10 of 10
Prevention of Esophageal Varices by Beta-Adrenergic Blockers
NCT00006398
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
NCT00004266
History of Hepatitis C in Volunteer Blood Donors
NCT00001982
Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
NCT00004660
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
NCT00001254
The Treatment and Natural History of Acromegaly
NCT00001981
Assessment of Sympathetic Nervous System Activity by Microneurography Recording Technique
NCT00341770
Determination of Kidney Function
NCT00001978
Treatment of Zollinger-Ellison Syndrome
NCT00001241
Evaluating Patients With Abnormal Levels of Gastric Acid
NCT00001240
Use of Biopsy Punch for Skin Biopsies for Fibroblasts Culturing
NCT00340912
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
NCT00001228
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223
Drug Therapy in Lupus Nephropathy
NCT00001212
Diabetes Control and Complications Trial (DCCT)
NCT00360815
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
NCT00001191
Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians
NCT00340132
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas
NCT00001165
Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian Community
NCT00339482
Studies With 1,25-Dihydroxycholecalciferol
NCT00001151
Written Self-disclosure for Youth Abdominal Pain
NCT00062608
Free-Living Physical Activity and Energy Expenditure
NCT00062998
Medical and Surgical Treatment of Esophageal Reflux
NCT00061724
ORWH:SCOR - Sex/Gender Factors Affecting Women's Health
NCT00068120
Native Hawaiian Diabetes Intervention Program
NCT00006165
Benefits and Risks of Newborn Screening for Cystic Fibrosis
NCT00014950
Improving Medication Adherence in Comorbid Conditions
NCT00072891
Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia
NCT00059670
Medical College of Georgia FitKid Project
NCT00061841
African-American Diabetes Intervention Project
NCT00006160
Exercise Amenorrhea Stress and Bone Health in Adolescents
NCT00441402
Effectiveness of Primary Care Physicians in Delivering Weight Control Counseling
NCT00017706
Impact of Non-Commercialism Policy in Seattle Schools
NCT00065000
Cognition, Steroids, and Imaging in Cushings Disease
NCT00081341
Diet and Physical Activity Interactions in Obesity
NCT00067964
Depression In Juvenile Diabetics
NCT00005116
Computer Intervention for Prevention of Weight Regain
NCT00067145
Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis
NCT00059449
A Pilot Study of Diabetes Risk Reduction Program With WIC Mothers(The Special Supplemental Nutrition Program for Women, Infants, and Children) Overweight WIC Mothers
NCT00944060
Clinical Approaches to Ileal Pouch Dysfunction
NCT00293553
What is open in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) pipeline
50 recruiting of 490 indexed (10% open); 398 completed (81%).
Phase mix: 69 late (III/IV) vs 178 early (I/II) (early-phase heavy).
Top condition: Obesity (25 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): open-pipeline peers nationwide
Peers matched on 490 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 490 trials (± recruiting share)
- Beth Israel Deaconess Medical Center · 488 trials · 14% recruiting
- Fred Hutchinson Cancer Center · 483 trials · 12% recruiting
- National Heart, Lung, and Blood Institute (NHLBI) · 501 trials · 12% recruiting
- H. Lee Moffitt Cancer Center and Research Institute · 502 trials · 16% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Mirati Therapeutics · 10% recruiting · 49 trials
- James J. Peters Veterans Affairs Medical Center · 10% recruiting · 39 trials
- California Pacific Medical Center Research Institute · 10% recruiting · 29 trials
- National Institute of Environmental Health Sciences (NIEHS) · 10% recruiting · 145 trials
Related
What to do with this National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) page
490 registered trials is a research-attention snapshot, not an endorsement of National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) or any single study.
- 50 of National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) pipeline card: 490 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.